NCT00081978View on ClinicalTrials.gov

TMC125-C223: TMC125 in HIV-1 Infected Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

October 31, 2005

Conditions
HIV Infection
Interventions
DRUG

TMC125

All Listed Sponsors
lead

Tibotec Pharmaceuticals, Ireland

INDUSTRY

NCT00081978 - TMC125-C223: TMC125 in HIV-1 Infected Subjects | Biotech Hunter | Biotech Hunter